Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Experimental parasitology

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/EXPR.1998.4282PMID 9676710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Design of Orally Active Iron Chelators

  2005cited by this paper
• The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release.

  1997cited by this paper
• Oxidative stress in malaria; implications for prevention and therapy

  1996cited by this paper
• Iron and infection.

  1996cited by this paper
• Clinical studies of iron chelators in malaria.

  1996cited by this paper
• Iron chelators: mode of action as antimalarials.

  1996cited by this paper
• Chemical Determinants of antimalarial activity of reversed siderophores

  1996cited by this paper
• Oral iron chelation.

  1996cited by this paper
• Results of long-term iron-chelating therapy.

  1996cited by this paper
• Iron and infection.

  1996cited by this paper
• Linkage of cell-mediated immunity to iron metabolism.

  1995cited by this paper
• Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores

  1995cited by this paper
• Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.

  1995cited by this paper
• Evaluation of a Liposome System for the Delivery of Desferrioxamine to Lungs in Rats

  1994cited by this paper
• The transport of two iron chelators, desferrioxamine B and L1, across Caco‐2 monolayers

  1994cited by this paper
• Malaria pigment and extracellular iron. Possible target for iron chelating agents.

  1993cited by this paper
• Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens.

  1992cited by this paper
• Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria.

  1992cited by this paper
• Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand.

  1992cited by this paper
• The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.

  1992cited by this paper
• Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways.

  1992cited by this paper
• Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria

  1991cited by this paper
• Parasite uptake of desferroxamine: a prerequisite for antimalarial activity

  1990cited by this paper
• Differential effects of liposome-entrapped desferrioxamine on proliferation and erythroid differentiation of murine erythroleukemic Friend cells.

  1989cited by this paper
• Deferoxamine inhibition of malaria is independent of host iron status

  1988cited by this paper
• Recent trends in the epidemiology and control of malaria.

  1987cited by this paper
• Desferrioxamine Suppresses Plasmodium falciparum in Aotus Monkeys 1

  1987cited by this paper
• Antimalarial activity of selected aromatic chelators. IV. Cation uptake by Plasmodium falciparum in the presence of oxines and siderochromes.

  1986cited by this paper
• Plasmodium vinckei: suppression of mouse infections with desferrioxamine B.

  1985cited by this paper
• Liposome‐encapsulated Desferrioxamine in Experimental Iron Overload

  1981cited by this paper
• Liposome Entrapped Desferrioxamine and Iron Transporting Ionophores: a New Approach to Iron Chelation Therapy

  1979cited by this paper
• Pharmacokinetics of the iron chelator desperrioxamine as affected by liposome encapsulation: potential in treatment of chronic hemosiderosis.

  1978cited by this paper
• Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

  1978cited by this paper
• Active immunization against the malaria parasite Plasmodium berghei in mice: sulfathiazole treatment of a P. berghei infection and development of immunity.

  1977cited by this paper
• Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

  1970cited by this paper
• The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism

  1964cited by this paper

• A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes.

  2023cites this paper
• Liposomes for malaria management: the evolution from 1980 to 2020

  2021cites this paper
• Nanoparticle Vaccines Against Infectious Diseases

  2018cites this paper
• Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines

  2017cites this paper
• A Novel Approach for Malaria Treatment

  2015cites this paper
• Nanomedicine against malaria.

  2014cites this paper
• Lipid nanocarriers and molecular targets for malaria chemotherapy.

  2014cites this paper
• Advances in nanomedicines for malaria treatment.

  2013cites this paper
• Development of nanovectors for the targeted drug delivery of antimalarials

  2013cites this paper
• Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors

  2011cites this paper
• A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro.

  2011cites this paper
• Intracellular Bacteria and Protozoa

  2011cites this paper
• Nanotechnology applied to the treatment of malaria.

  2010cites this paper
• Heme Oxygenase‐1‐Generated Biliverdin Ameliorates Experimental Murine Colitis

  2005cites this paper
• Polyamines, Iron and Pneumocystis carinii

  2004cites this paper
• Antimalarial effect of iron chelators.

  2002cites this paper
• Action of Deferoxamine against Pneumocystis carinii

  2001cites this paper
• Action of Deferoxamine againstPneumocystis carinii

  2001cites this paper
• Tuftsin-bearing liposomes in treatment of macrophage-based infections.

  2000cites this paper
• Liposomes for Local Sustained Drug Release

  2000cites this paper
• Absorption and biodistribution of 111indium-labelled desferrioxamine (111In-DFO) after subcutaneous injection of 111In-DFO liposomes.

  1999cites this paper